|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021747,
umls-concept:C0035525,
umls-concept:C0038952,
umls-concept:C0039260,
umls-concept:C0205466,
umls-concept:C0332161,
umls-concept:C0392756,
umls-concept:C0524910,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2239176,
umls-concept:C2603343,
umls-concept:C2911692
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2007-2-16
|
|
pubmed:abstractText |
The long-term benefit for chronic hepatitis C (CHC) patients treated with interferon (IFN)/ribavirin (RBV) combination therapy remains unclear. We aimed to evaluate the long-term effects of IFN monotherapy and IFN/RBV combination therapy on reducing hepatocellular carcinoma (HCC) and mortality in patients with chronic hepatitis C virus (HCV) infection, adjusting for risk factors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
985-94
|
|
pubmed:meshHeading |
pubmed-meshheading:17302368-Adult,
pubmed-meshheading:17302368-Antiviral Agents,
pubmed-meshheading:17302368-Carcinoma, Hepatocellular,
pubmed-meshheading:17302368-Cohort Studies,
pubmed-meshheading:17302368-Drug Therapy, Combination,
pubmed-meshheading:17302368-Female,
pubmed-meshheading:17302368-Follow-Up Studies,
pubmed-meshheading:17302368-Hepacivirus,
pubmed-meshheading:17302368-Hepatitis C, Chronic,
pubmed-meshheading:17302368-Humans,
pubmed-meshheading:17302368-Interferons,
pubmed-meshheading:17302368-Male,
pubmed-meshheading:17302368-Middle Aged,
pubmed-meshheading:17302368-Ribavirin,
pubmed-meshheading:17302368-Survival Rate,
pubmed-meshheading:17302368-Taiwan,
pubmed-meshheading:17302368-Time Factors
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
|
|
pubmed:affiliation |
Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
